NCT05518721 is a NA clinical trial of Hallux Rigidus Treatment in Hallux Rigidus, sponsored by John Femino.

Who is sponsoring NCT05518721?

NCT05518721 is sponsored by John Femino.

What drugs are being tested in NCT05518721?

Interventions in NCT05518721: Hallux Rigidus Treatment.

What condition does NCT05518721 study?

NCT05518721 studies Hallux Rigidus.

Is NCT05518721 still recruiting?

NCT05518721 is currently withdrawn. Last updated 20 December 2023.

Last reviewed 2023-12-20 · How we verify

NCT05518721

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Synthetic Cartilage Implant Versus Interposition Arthroplasty in Hallux Rigidus Treatment: A Randomized Clinical Trial

Withdrawn NA Last updated 20 December 2023

What this trial tests

NA trial testing Hallux Rigidus Treatment in Hallux Rigidus. Withdrawn.

Timeline

5 July 2022

Primary endpoint
14 December 2023

14 December 2023

Quick facts

Lead sponsor	John Femino
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Start date	5 July 2022
Primary completion	14 December 2023
Estimated completion	14 December 2023
Sites	1 location across United States

Drugs / interventions tested

Hallux Rigidus Treatment

Conditions studied

Hallux Rigidus — all drugs for Hallux Rigidus →

Sponsor

John Femino

Who can join

Adults 18 to 75, any sex, with Hallux Rigidus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A minimum of 100 patients with grade III hallux rigidus will be randomized in two parallel groups for surgical care. The first group will be submitted to the insertion of a synthetic cartilage implant at the metatarsophalangeal (MTP) joint. The second group will receive a dermal interposition arthroplasty at the MTP. Both sides will undergo the same post-operative protocol. Pain, complications, and functional results will be evaluated in a minimal of two years of follow-up.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hallux Rigidus

Currently open trials in the same condition.

NCT05555459 — Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation · NA · recruiting
NCT05795127 — Risk for Reoperation After First MTP Joint Arthrodesis · active not recruiting
NCT04590313 — Efficacy of First MTPJ Arthrodesis as a Treatment in Hallux Rigidus · NA · active not recruiting
NCT04473196 — The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion · NA · recruiting

Other John Femino trials

Trials by the same sponsor.

NCT05562154 — Lateral Approach Versus Anterior Approach in Total Ankle Replacement · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05518721 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by John Femino
Last refreshed: 20 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05518721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing